169 related articles for article (PubMed ID: 31371165)
1. A Pragmatic Trial of Symptom-Based Inhaled Corticosteroid Use in African-American Children with Mild Asthma.
Sumino K; Bacharier LB; Taylor J; Chadwick-Mansker K; Curtis V; Nash A; Jackson-Triggs S; Moen J; Schechtman KB; Garbutt J; Castro M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):176-185.e2. PubMed ID: 31371165
[TBL] [Abstract][Full Text] [Related]
2. Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
Dy T; Lewis EM; Murugan V; Gehlert S; Taylor J; Garbutt J; Bacharier LB; Castro M; Sumino K
Respir Med; 2018 Apr; 137():201-205. PubMed ID: 29605205
[TBL] [Abstract][Full Text] [Related]
3. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
Martinez FD; Chinchilli VM; Morgan WJ; Boehmer SJ; Lemanske RF; Mauger DT; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bade E; Covar RA; Friedman NJ; Guilbert TW; Heidarian-Raissy H; Kelly HW; Malka-Rais J; Mellon MH; Sorkness CA; Taussig L
Lancet; 2011 Feb; 377(9766):650-7. PubMed ID: 21324520
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
5. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
6. Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma.
Gerald JK; Gerald LB; Vasquez MM; Morgan WJ; Boehmer SJ; Lemanske RF; Mauger DT; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bade E; Covar RA; Guilbert TW; Heidarian-Raissy H; Kelly HW; Malka-Rais J; Sorkness CA; Taussig LM; Chinchilli VM; Martinez FD
J Allergy Clin Immunol Pract; 2015; 3(4):540-6.e3. PubMed ID: 25783161
[TBL] [Abstract][Full Text] [Related]
7. Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects.
Wells KE; Cajigal S; Peterson EL; Ahmedani BK; Kumar R; Lanfear DE; Burchard EG; Williams LK
J Allergy Clin Immunol; 2016 May; 137(5):1364-1369.e2. PubMed ID: 27016472
[TBL] [Abstract][Full Text] [Related]
8. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
9. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
10. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.
Calhoun WJ; Ameredes BT; King TS; Icitovic N; Bleecker ER; Castro M; Cherniack RM; Chinchilli VM; Craig T; Denlinger L; DiMango EA; Engle LL; Fahy JV; Grant JA; Israel E; Jarjour N; Kazani SD; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Lugogo N; Martin RJ; Meyers DA; Moore WC; Pascual R; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Wasserman SI; Walter MJ; Wechsler ME; Boushey HA;
JAMA; 2012 Sep; 308(10):987-97. PubMed ID: 22968888
[TBL] [Abstract][Full Text] [Related]
11. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.
Pruteanu AI; Chauhan BF; Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):931-1046. PubMed ID: 25504973
[TBL] [Abstract][Full Text] [Related]
13. Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
Israel E; Cardet JC; Carroll JK; Fuhlbrigge AL; She L; Rockhold FW; Maher NE; Fagan M; Forth VE; Yawn BP; Arias Hernandez P; Kruse JM; Manning BK; Rodriguez-Louis J; Shields JB; Ericson B; Colon-Moya AD; Madison S; Coyne-Beasley T; Hammer GM; Kaplan BM; Rand CS; Robles J; Thompson O; Wechsler ME; Wisnivesky JP; McKee MD; Jariwala SP; Jerschow E; Busse PJ; Kaelber DC; Nazario S; Hernandez ML; Apter AJ; Chang KL; Pinto-Plata V; Stranges PM; Hurley LP; Trevor J; Casale TB; Chupp G; Riley IL; Shenoy K; Pasarica M; Calderon-Candelario RA; Tapp H; Baydur A; Pace WD
N Engl J Med; 2022 Apr; 386(16):1505-1518. PubMed ID: 35213105
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
[TBL] [Abstract][Full Text] [Related]
15. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
16. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
19. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
20. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
Ng D; Salvio F; Hicks G
Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
